Valued at $1.25 billion, the deal expands BioNTech’s cancer drug portfolio and heads off royalty costs it could have owed ...

GTC Paris conference for developers, researchers and business leaders this week unfurled several new growth opportunities for ...

Roger Altman, Evercore founder and senior chairman, joins ‘Squawk on the Street’ to discuss the state of the economy, the ...

Under normal circumstances, moderating inflation and a weakening labor market would make an easy case for interest rate ...